Showing results (281-290 of 361) with videos related to
Sort By:
Pageof 37
Hepatology (Baltimore, Md.)|November 1, 1995
Hepatitis B virus precore/core variation and interferon therapyG Fattovich, G McIntyre, M Thursz, et al.Gut|September 1, 1982
Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP)I V Weller, M F Bassendine, A Craxi, et al.Journal of Hepatology|January 1, 1985
Studies of HBV replication during acute hepatitis followed by recovery and acute hepatitis progressing to chronic diseaseA S Lok, P Karayiannis, T P Jowett, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNAG R Foster, A M Ackrill, R D Goldin, et al.Gut|August 1, 1989
Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence responseM G Brook, J A McDonald, P Karayiannis, et al.Lancet (London, England)|September 9, 1989
Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infectionW F Carman, M R Jacyna, S Hadziyannis, et al.Hepatology (Baltimore, Md.)|August 1, 1991
Association of a precore genomic variant of hepatitis B virus with fulminant hepatitisW F Carman, E A Fagan, S Hadziyannis, et al.Journal of Clinical Pathology|October 1, 1981
Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitisM Bamber, A K Murray, I V Weller, et al.Gut|February 1, 1983
Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapyA Craxi, I V Weller, M F Bassendine, et al.Pageof 37